Works by Takahashi, Masato


Results: 160
    1

    Radiofrequency Ablation of Breast Cancer: A Retrospective Study.

    Published in:
    2018
    By:
    • Toshikazu Ito;
    • Shoji Oura;
    • Shinji Nagamine;
    • Masato Takahashi;
    • Naohito Yamamoto;
    • Noboru Yamamichi;
    • Mitsuharu Earashi;
    • Hiroyoshi Doihara;
    • Shigeru Imoto;
    • Shoshu Mitsuyama;
    • Kohei Akazawa;
    • Ito, Toshikazu;
    • Oura, Shoji;
    • Nagamine, Shinji;
    • Takahashi, Masato;
    • Yamamoto, Naohito;
    • Yamamichi, Noboru;
    • Earashi, Mitsuharu;
    • Doihara, Hiroyoshi;
    • Imoto, Shigeru
    Publication type:
    journal article
    2
    3
    4
    5
    6
    7
    8

    Health-related quality of life and estimation of the minimally important difference in the Functional Assessment of Cancer Therapy-Endocrine Symptom score in postmenopausal ER+/HER2- metastatic breast cancer with low sensitivity to endocrine therapy.

    Published in:
    PLoS ONE, 2022, v. 17, n. 11, p. 1, doi. 10.1371/journal.pone.0278344
    By:
    • Kikawa, Yuichiro;
    • Hagiwara, Yasuhiro;
    • Fujisawa, Tomomi;
    • Araki, Kazuhiro;
    • Iwamoto, Takayuki;
    • Sangai, Takafumi;
    • Shien, Tadahiko;
    • Takao, Shintaro;
    • Nishimura, Reiki;
    • Takahashi, Masato;
    • Toyama, Tatsuya;
    • Aihara, Tomohiko;
    • Mukai, Hirofumi;
    • Taira, Naruto
    Publication type:
    Article
    9
    10
    11
    12

    Programmed death ligand 1-positive immune cells in primary tumor or metastatic axillary lymph nodes can predict prognosis of triple-negative breast cancer even when present at < 1% in the tumor region.

    Published in:
    Breast Cancer (13406868), 2023, v. 30, n. 3, p. 497, doi. 10.1007/s12282-023-01442-9
    By:
    • Tomioka, Nobumoto;
    • Hatanaka, Kanako C.;
    • Okuyama, Dai;
    • Watanabe, Ken-ichi;
    • Yamamoto, Mitsugu;
    • Maeda, Hideki;
    • Tachikawa, Hanae;
    • Kuwahara, Sayuri;
    • Shimizu, Ai;
    • Suzuki, Hiroaki;
    • Hatanaka, Yutaka;
    • Takahashi, Masato
    Publication type:
    Article
    13

    Efficacy and safety of talazoparib in Japanese patients with germline BRCA-mutated locally advanced or metastatic breast cancer: results of the phase 1 dose-expansion study.

    Published in:
    Breast Cancer (13406868), 2022, v. 29, n. 6, p. 1088, doi. 10.1007/s12282-022-01390-w
    By:
    • Kotani, Haruru;
    • Masuda, Norikazu;
    • Yamashita, Toshinari;
    • Naito, Yoichi;
    • Taira, Tetsuhiko;
    • Inoue, Kenichi;
    • Takahashi, Masato;
    • Yonemori, Kan;
    • Toyoizumi, Shigeyuki;
    • Mori, Yuko;
    • Nagasawa, Takashi;
    • Hori, Natsuki;
    • Iwata, Hiroji
    Publication type:
    Article
    14
    15
    16

    Correction to: Prevalence of mutations in BRCA and homologous recombination repair genes and real-world standard of care of Asian patients with HER2-negative metastatic breast cancer starting first-line systemic cytotoxic chemotherapy: subgroup analysis of the global BREAKOUT study

    Published in:
    2022
    By:
    • Koh, Su-Jin;
    • Ohsumi, Shozo;
    • Takahashi, Masato;
    • Fukuma, Eisuke;
    • Jung, Kyung Hae;
    • Ishida, Takanori;
    • Dai, Ming-Shen;
    • Chang, Chuan-Hsun;
    • Dalvi, Tapashi;
    • Walker, Graham;
    • Bennett, James;
    • O'Shaughnessy, Joyce;
    • Balmaña, Judith
    Publication type:
    Correction Notice
    17
    18

    Quality of life in a randomized phase II study to determine the optimal dose of 3-week cycle nab-paclitaxel in patients with metastatic breast cancer.

    Published in:
    Breast Cancer (13406868), 2022, v. 29, n. 1, p. 131, doi. 10.1007/s12282-021-01290-5
    By:
    • Taira, Naruto;
    • Kashiwabara, Kosuke;
    • Tsurutani, Junji;
    • Kitada, Masahiro;
    • Takahashi, Masato;
    • Kato, Hiroaki;
    • Kikawa, Yuichiro;
    • Sakata, Eiko;
    • Naito, Yoichi;
    • Hasegawa, Yoshie;
    • Saito, Tsuyoshi;
    • Iwasa, Tsutomu;
    • Takashima, Tsutomu;
    • Aihara, Tomohiko;
    • Mukai, Hirofumi;
    • Hara, Fumikata
    Publication type:
    Article
    19

    Prevalence of mutations in BRCA and homologous recombination repair genes and real-world standard of care of Asian patients with HER2-negative metastatic breast cancer starting first-line systemic cytotoxic chemotherapy: subgroup analysis of the global BREAKOUT study

    Published in:
    Breast Cancer (13406868), 2022, v. 29, n. 1, p. 92, doi. 10.1007/s12282-021-01283-4
    By:
    • Koh, Su-Jin;
    • Ohsumi, Shozo;
    • Takahashi, Masato;
    • Fukuma, Eisuke;
    • Jung, Kyung Hae;
    • Ishida, Takanori;
    • Dai, Ming-Shen;
    • Chang, Chuan-Hsun;
    • Dalvi, Tapashi;
    • Walker, Graham;
    • Bennett, James;
    • O'Shaughnessy, Joyce;
    • Balmaña, Judith
    Publication type:
    Article
    20

    Japanese subpopulation analysis of MONARCH 2: phase 3 study of abemaciclib plus fulvestrant for treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer that progressed on endocrine therapy.

    Published in:
    Breast Cancer (13406868), 2021, v. 28, n. 5, p. 1038, doi. 10.1007/s12282-021-01239-8
    By:
    • Inoue, Kenichi;
    • Masuda, Norikazu;
    • Iwata, Hiroji;
    • Takahashi, Masato;
    • Ito, Yoshinori;
    • Miyoshi, Yasuo;
    • Nakayama, Takahiro;
    • Mukai, Hirofumi;
    • van der Walt, Jan-Stefan;
    • Mori, Joji;
    • Sakaguchi, Sachi;
    • Kawaguchi, Tsutomu;
    • Tanizawa, Yoshinori;
    • Llombart-Cussac, Antonio;
    • Sledge Jr, George W.;
    • Toi, Masakazu
    Publication type:
    Article
    21

    Correction to: The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2018 edition.

    Published in:
    2021
    By:
    • Shimoi, Tatsunori;
    • Nagai, Shigenori E.;
    • Yoshinami, Tetsuhiro;
    • Takahashi, Masato;
    • Arioka, Hitoshi;
    • Ishihara, Mikiya;
    • Kikawa, Yuichiro;
    • Koizumi, Kei;
    • Kondo, Naoto;
    • Sagara, Yasuaki;
    • Takada, Masahiro;
    • Takano, Toshimi;
    • Tsurutani, Junji;
    • Naito, Yoichi;
    • Nakamura, Rikiya;
    • Hattori, Masaya;
    • Hara, Fimikata;
    • Hayashi, Naoki;
    • Mizuno, Toshiro;
    • Miyashita, Minoru
    Publication type:
    Correction Notice
    22
    23

    Prospective observational study of bevacizumab combined with paclitaxel as first- or second-line chemotherapy for locally advanced or metastatic breast cancer: the JBCRG-C05 (B-SHARE) study.

    Published in:
    Breast Cancer (13406868), 2021, v. 28, n. 1, p. 145, doi. 10.1007/s12282-020-01138-4
    By:
    • Yamamoto, Yutaka;
    • Yamashiro, Hiroyasu;
    • Toh, Uhi;
    • Kondo, Naoto;
    • Nakamura, Rikiya;
    • Kashiwaba, Masahiro;
    • Takahashi, Masato;
    • Tsugawa, Koichiro;
    • Ishikawa, Takashi;
    • Nakayama, Takahiro;
    • Ohtani, Shoichiro;
    • Takano, Toshimi;
    • Fujisawa, Tomomi;
    • Toyama, Tatsuya;
    • Kawaguchi, Hidetoshi;
    • Mashino, Kojiro;
    • Tanino, Yuichi;
    • Morita, Satoshi;
    • Toi, Masakazu;
    • Ohno, Shinji
    Publication type:
    Article
    24

    The efficacy of sequential second-line endocrine therapies (ETs) in postmenopausal estrogen receptor-positive and HER2-negative metastatic breast cancer patients with lower sensitivity to initial ETs.

    Published in:
    Breast Cancer (13406868), 2020, v. 27, n. 5, p. 973, doi. 10.1007/s12282-020-01095-y
    By:
    • Iwamoto, Takayuki;
    • Fujisawa, Tomomi;
    • Shien, Tadahiko;
    • Araki, Kazuhiro;
    • Sakamaki, Kentaro;
    • Sangai, Takafumi;
    • Kikawa, Yuichiro;
    • Takao, Shintaro;
    • Nishimura, Reiki;
    • Takahashi, Masato;
    • Aihara, Tomohiko;
    • Mukai, Hirofumi;
    • Taira, Naruto
    Publication type:
    Article
    25

    Outcomes of trastuzumab therapy in HER2-positive early breast cancer patients: extended follow-up of JBCRG-cohort study 01.

    Published in:
    Breast Cancer (13406868), 2020, v. 27, n. 4, p. 631, doi. 10.1007/s12282-020-01057-4
    By:
    • Yamashiro, Hiroyasu;
    • Iwata, Hiroji;
    • Masuda, Norikazu;
    • Yamamoto, Naohito;
    • Nishimura, Reiki;
    • Ohtani, Shoichiro;
    • Sato, Nobuaki;
    • Takahashi, Masato;
    • Kamio, Takako;
    • Yamazaki, Kosuke;
    • Saito, Tsuyoshi;
    • Kato, Makoto;
    • Lee, Tecchuu;
    • Kuroi, Katsumasa;
    • Takano, Toshimi;
    • Yasuno, Shinji;
    • Morita, Satoshi;
    • Ohno, Shinji;
    • Toi, Masakazu;
    • the JBCRG-C01 Collaborative Group
    Publication type:
    Article
    26

    The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2018 edition.

    Published in:
    Breast Cancer (13406868), 2020, v. 27, n. 3, p. 322, doi. 10.1007/s12282-020-01085-0
    By:
    • Shimoi, Tatsunori;
    • Nagai, Shigenori E.;
    • Yoshinami, Tetsuhiro;
    • Takahashi, Masato;
    • Arioka, Hitoshi;
    • Ishihara, Mikiya;
    • Kikawa, Yuichiro;
    • Koizumi, Kei;
    • Kondo, Naoto;
    • Sagara, Yasuaki;
    • Takada, Masahiro;
    • Takano, Toshimi;
    • Tsurutani, Junji;
    • Naito, Yoichi;
    • Nakamura, Rikiya;
    • Hattori, Masaya;
    • Hara, Fimikata;
    • Hayashi, Naoki;
    • Mizuno, Toshiro;
    • Miyashita, Minoru
    Publication type:
    Article
    27

    Bi-weekly eribulin therapy for metastatic breast cancer: a multicenter phase II prospective study (JUST-STUDY).

    Published in:
    Breast Cancer (13406868), 2018, v. 25, n. 4, p. 438, doi. 10.1007/s12282-018-0843-y
    By:
    • Ohtani, Shoichiro;
    • Nakayama, Takahiro;
    • Yoshinami, Tetsuhiro;
    • Watanabe, Ken-ichi;
    • Hara, Fumikata;
    • Sagara, Yasuaki;
    • Kawaguchi, Hidetoshi;
    • Higaki, Kenji;
    • Matsunami, Nobuki;
    • Hasegawa, Yoshie;
    • Takahashi, Masato;
    • Mizutani, Makiko;
    • Morimoto, Takashi;
    • Sato, Masako;
    • Itoh, Mitsuya;
    • Morita, Satoshi;
    • Masuda, Norikazu
    Publication type:
    Article
    28
    29
    30

    Post-relapse survival in patients with the early and late distant recurrence in estrogen receptor-positive HER2-negative breast cancer.

    Published in:
    Breast Cancer (13406868), 2017, v. 24, n. 3, p. 473, doi. 10.1007/s12282-016-0730-3
    By:
    • Ogiya, Akiko;
    • Yamazaki, Kieko;
    • Horii, Rie;
    • Shien, Tadahiko;
    • Horimoto, Yoshiya;
    • Masuda, Norikazu;
    • Inao, Touko;
    • Hosoda, Mitsuchika;
    • Ishida, Naoko;
    • Osako, Tomofumi;
    • Takahashi, Masato;
    • Endo, Yumi;
    • Miyoshi, Yuichiro;
    • Yasojima, Hiroyuki;
    • Tomioka, Nobumoto;
    • Yamashita, Hiroko
    Publication type:
    Article
    31

    Clinicopathological factors predicting early and late distant recurrence in estrogen receptor-positive, HER2-negative breast cancer.

    Published in:
    Breast Cancer (13406868), 2016, v. 23, n. 6, p. 830, doi. 10.1007/s12282-015-0649-0
    By:
    • Yamashita, Hiroko;
    • Ogiya, Akiko;
    • Shien, Tadahiko;
    • Horimoto, Yoshiya;
    • Masuda, Norikazu;
    • Inao, Touko;
    • Osako, Tomofumi;
    • Takahashi, Masato;
    • Endo, Yumi;
    • Hosoda, Mitsuchika;
    • Ishida, Naoko;
    • Horii, Rie;
    • Yamazaki, Kieko;
    • Miyoshi, Yuichiro;
    • Yasojima, Hiroyuki;
    • Tomioka, Nobumoto
    Publication type:
    Article
    32
    33

    Prevalence and differentiation of hereditary breast and ovarian cancers in Japan.

    Published in:
    Breast Cancer (13406868), 2015, v. 22, n. 5, p. 462, doi. 10.1007/s12282-013-0503-1
    By:
    • Nakamura, Seigo;
    • Takahashi, Masato;
    • Tozaki, Mitsuhiro;
    • Nakayama, Takahiro;
    • Nomizu, Tadashi;
    • Miki, Yoshio;
    • Murakami, Yoshie;
    • Aoki, Daisuke;
    • Iwase, Takuji;
    • Nishimura, Seiichiro;
    • Yamauchi, Hideko;
    • Ohsumi, Shozo;
    • Baba, Shinichi;
    • Shimizu, Tadao
    Publication type:
    Article
    34
    35
    36

    Predictive factors for anthracycline-based chemotherapy for human breast cancer.

    Published in:
    Breast Cancer (13406868), 2010, v. 17, n. 2, p. 103, doi. 10.1007/s12282-009-0152-6
    By:
    • Miyoshi, Yasuo;
    • Kurosumi, Masafumi;
    • Kurebayashi, Junichi;
    • Matsuura, Nariaki;
    • Takahashi, Masato;
    • Tokunaga, Eriko;
    • Egawa, Chiyomi;
    • Masuda, Norikazu;
    • Kono, Seishi;
    • Morimoto, Koji;
    • Kim, Seung;
    • Okishiro, Masatsugu;
    • Yanagisawa, Tetsu;
    • Ueda, Satsuki;
    • Taguchi, Tetsuya;
    • Tamaki, Yasuhiro;
    • Noguchi, Shinzaburo
    Publication type:
    Article
    37
    38
    39
    40

    Efficiency of High Magnetic Fields in Solid-state NMR.

    Published in:
    Chemistry Letters, 2016, v. 45, n. 2, p. 209, doi. 10.1246/cl.151063
    By:
    • Kenjiro Hashi;
    • Kenzo Deguchi;
    • Toshio Yamazaki;
    • Shinobu Ohki;
    • Shinji Matsumoto;
    • Gen Nishijima;
    • Atsushi Goto;
    • Kazuhiko Yamada;
    • Takashi Noguchi;
    • Shuji Sakai;
    • Masato Takahashi;
    • Yoshinori Yanagisawa;
    • Seiya Iguchi;
    • Hideaki Maeda;
    • Ryoji Tanaka;
    • Takahiro Nemoto;
    • Hiroto Suematsu;
    • To, Janet;
    • Torres, Jaume;
    • Konstantin Pervushin
    Publication type:
    Article
    41

    Pertuzumab retreatment for HER2‐positive advanced breast cancer: A randomized, open‐label phase III study (PRECIOUS).

    Published in:
    Cancer Science, 2022, v. 113, n. 9, p. 3169, doi. 10.1111/cas.15474
    By:
    • Yamamoto, Yutaka;
    • Iwata, Hiroji;
    • Taira, Naruto;
    • Masuda, Norikazu;
    • Takahashi, Masato;
    • Yoshinami, Tetsuhiro;
    • Ueno, Takayuki;
    • Toyama, Tatsuya;
    • Yamanaka, Takashi;
    • Takano, Toshimi;
    • Kashiwaba, Masahiro;
    • Tsugawa, Koichiro;
    • Hasegawa, Yoshie;
    • Tamura, Kenji;
    • Tada, Hiroshi;
    • Hara, Fumikata;
    • Fujisawa, Tomomi;
    • Niikura, Naoki;
    • Saji, Shigehira;
    • Morita, Satoshi
    Publication type:
    Article
    42
    43
    44
    45
    46
    47
    48
    49
    50